Differences in prevalence and risk factors of non-communicable diseases between young people living with HIV (YLWH) and young general population in Cambodia.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
07
2021
accepted:
01
06
2022
entrez:
21
6
2022
pubmed:
22
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Understanding non-communicable diseases (NCDs) among young people living with HIV (YLWH) is critical given the potential for aging-associated comorbidities resulting from HIV, especially in Cambodia where such data are limited. Therefore, we examined the prevalence and correlates of NCDs in YLWH and compared it to a nationally representative sample of young people not otherwise infected. We collected data from a sample of 370 YLWH aged 18-29 years attending three HIV clinics in Cambodia between 2019 and 2020. Our comparison group were 486 young people who participated in the Ministry of Health/WHO 2016 Noncommunicable Disease Risk Factor Surveillance (STEP survey). Both surveys used a standardized questionnaire to collect information on lifestyle factors and World Health Organization protocols for physical and biochemical measurements. We compared the prevalence of diabetes, hypertension, and high cholesterolemia between the two groups and examined the relationship between these conditions and HIV. We found 16 (4%), 22 (6%), and 72 (20%) had diabetes, hypertension, and high cholesterolemia, respectively, among YLWH, compared to 4 (1%), 22 (4%), and 49 (11%) among the general population. In logistic regression, YLWH were at higher odds of diabetes/prediabetes and high cholesterolemia compared with the young general population, aOR = 6.64 (95% CI 3.62-12.19) and aOR = 7.95 (95% CI 3.98-15.87), respectively. Our findings demonstrate that YLWH in Cambodia face multiple metabolic disorders and NCDs despite their young age and that accessible screening measures and treatment for these conditions are needed in order to combat NCDs in the future.
Identifiants
pubmed: 35727763
doi: 10.1371/journal.pone.0269989
pii: PONE-D-21-24528
pmc: PMC9212152
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0269989Subventions
Organisme : NICHD NIH HHS
ID : P2C HD041022
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009590
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
AIDS. 2018 Jul 1;32 Suppl 1:S21-S32
pubmed: 29952787
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S8-16
pubmed: 25117964
Lancet Infect Dis. 2015 Jul;15(7):810-8
pubmed: 26070969
Open Cardiovasc Med J. 2011;5:49-63
pubmed: 21643501
PLoS One. 2019 Aug 9;14(8):e0221022
pubmed: 31398244
Implement Sci. 2015 Mar 11;10:32
pubmed: 25889672
Cien Saude Colet. 2019 May 30;24(5):1903-1914
pubmed: 31166523
AIDS. 2012 Dec;26 Suppl 2:S97-S103
pubmed: 23303438
BMC Infect Dis. 2018 Aug 28;18(1):428
pubmed: 30153797
PLoS One. 2017 Nov 9;12(11):e0187591
pubmed: 29121661
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S2-7
pubmed: 25117958
Circulation. 2019 Jul 9;140(2):e98-e124
pubmed: 31154814
Bull World Health Organ. 2016 Jul 1;94(7):484
pubmed: 27429484
Curr Opin HIV AIDS. 2011 Jul;6(4):266-71
pubmed: 21546831
PLoS One. 2018 Mar 29;13(3):e0191791
pubmed: 29596425
Eur Heart J. 2014 Jun 1;35(21):1373-81
pubmed: 24408888
AIDS. 2018 Jan 14;32(2):253-260
pubmed: 29135581
Lancet. 2013 Nov 2;382(9903):1466-7
pubmed: 24182530
Heart. 2009 Jul;95(14):1193-202
pubmed: 19564432
AIDS. 2016 Mar 27;30(6):899-908
pubmed: 26959354
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Healthcare (Basel). 2017 Mar 08;5(1):
pubmed: 28282852
Curr HIV/AIDS Rep. 2017 Dec;14(6):220-228
pubmed: 29080122
Int J Equity Health. 2017 Jul 14;16(1):125
pubmed: 28705242